Related Experiment Videos

Dermatomyositis and polymyositis in childhood

I Gamstorp1

  • 1Department of Pediatrics, University Hospital, Uppsala, Sweden.

Brain & Development
|January 1, 1990
PubMed

Insights

This review covers childhood dermatomyositis and polymyositis, detailing skin, muscle, and tendon symptoms. Early, high-dose corticosteroid treatment, potentially long-term, is key, with physiotherapy and antimetabolites as adjuncts.

Area of Science:

  • Pediatric Rheumatology
  • Dermatology
  • Neuromuscular Disorders

Background:

  • Childhood dermatomyositis and polymyositis are rare inflammatory myopathies.
  • Clinical presentation includes characteristic skin rashes and proximal muscle weakness.

Purpose of the Study:

  • To review clinical findings, diagnostic procedures, and treatment strategies for pediatric inflammatory myopathies.
  • To emphasize long-term management and potential sequelae.

Main Methods:

  • Retrospective review of 40-50 childhood cases over 30 years.
  • Analysis of clinical manifestations, diagnostic approaches, and treatment outcomes.
  • Evaluation of therapeutic responses to corticosteroids and antimetabolites.

Main Results:

  • Key symptoms include skin eruptions (knuckles, elbows, knees) and proximal muscle weakness.
  • Corticosteroids are the primary treatment, requiring high initial doses and potential long-term use.
  • Physiotherapy is crucial, and antimetabolites may be added for refractory cases.

Conclusions:

  • Early and aggressive treatment with corticosteroids is essential for managing pediatric dermatomyositis and polymyositis.
  • Long-term management, including physiotherapy, is often necessary for optimal outcomes.
  • Most children survive with minimal or no long-term complications with appropriate care.

Related Concept Videos